40 related articles for article (PubMed ID: 19129688)
1. Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia.
Miura K; Iida S; Hanamura I; Kato M; Banno S; Ishida T; Kusumoto S; Takeuchi G; Miwa H; Nitta M; Inagaki H; Eimoto T; Nomura K; Taniwaki M; Ueda R
Cancer Sci; 2003 Apr; 94(4):350-4. PubMed ID: 12824903
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells.
Azami Y; Tsuyama N; Abe Y; Sugai-Takahashi M; Kudo KI; Ota A; Sivasundaram K; Muramatsu M; Shigemura T; Sasatani M; Hashimoto Y; Saji S; Kamiya K; Hanamura I; Ikezoe T; Onodera M; Sakai A
Sci Rep; 2021 Mar; 11(1):5216. PubMed ID: 33664418
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic multiple myeloma resembling dysplastic megakaryocytes.
Xie W; Tang G; Li S; Yin CC; Xu J
Clin Case Rep; 2020 Mar; 8(3):568-569. PubMed ID: 32185061
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic multiple myeloma with amplification of the IGH-CCND1 gene fusion.
Alencar RN; Martinez GA; Cordeiro MG; Velloso EDRP
Hematol Transfus Cell Ther; 2023; 45(4):495-498. PubMed ID: 34862156
[No Abstract] [Full Text] [Related]
5. A Rare Coexistence of Smoldering Multiple Myeloma and JAK2-Positive Myeloproliferative Neoplasm: A Case of Dual Synchronous Hematological Malignancy.
Hammani A; Doghmi O; Allaoui M; Ababou M; Mahtat EM; El Maaroufi H; Doghmi K
Cureus; 2024 Jan; 16(1):e52622. PubMed ID: 38374866
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy.
Krishnan N; Price R; Kotchetkov R
Front Oncol; 2023; 13():1213942. PubMed ID: 37361582
[TBL] [Abstract][Full Text] [Related]
7. Development of multiple myeloma after 15 years of treatment for polycythemia vera and successful treatment using bortezomib: A case report.
Kimura H; Furukawa M; Mori H; Shiga Y; Asai J; Satoh K; Kai T
Clin Case Rep; 2022 Nov; 10(11):e6614. PubMed ID: 36415705
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Concomitant Diagnosis of Plasma Cell Leukemia in Patient With JAK2 Positive Myeloproliferative Neoplasm.
Kurian CJ; Thomas C; Houtmann S; Klumpp T; Binder AF
Front Oncol; 2020; 10():1497. PubMed ID: 32974181
[TBL] [Abstract][Full Text] [Related]
9. Essential Thrombocythaemia with Concomitant Waldenström Macroglobulinaemia: Case Report and Literature Review.
Lu N; Neoh CL; Ruan Z; Zhao L; Ying L; Zhang X; Chen S; Xu L
Onco Targets Ther; 2020; 13():3431-3435. PubMed ID: 32425546
[TBL] [Abstract][Full Text] [Related]
10. Extranodal marginal zone lymphoma of the uterine cervix with concomitant copy number gains of the
Takimoto T; Maegawa S; Tatsumi H; Nagoshi H; Chinen Y; Shimura Y; Kobayashi T; Horiike S; Nakamura S; Kitawaki J; Kuroda J; Taniwaki M
Oncol Lett; 2017 May; 13(5):3641-3645. PubMed ID: 28521466
[TBL] [Abstract][Full Text] [Related]
11. Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis.
Niscola P; Catalano G; Fratoni S; Scaramucci L; de Fabritiis P; Caravita T
Blood Res; 2013 Sep; 48(3):228-30. PubMed ID: 24086946
[No Abstract] [Full Text] [Related]
12. The emergence of non-secretory multiple myeloma during the non-cytotoxic treatment of essential thrombocythemia: a case report.
Leković D; Gotić M; Mitrović O; Radojković M; Bila J; Dencic-Fekete M; Kraguljac-Kurtović N; Peruničić-Jovanović M; Cokić V
J Med Case Rep; 2013 Sep; 7():224. PubMed ID: 24025541
[TBL] [Abstract][Full Text] [Related]
13. Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients.
Martin LD; Harizanova J; Zhu G; Righolt CH; Belch AR; Mai S; Pilarski LM
Genes Chromosomes Cancer; 2012 Aug; 51(8):727-42. PubMed ID: 22489023
[TBL] [Abstract][Full Text] [Related]
14. Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia.
Hwang Y; Lee JY; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2011 Jun; 33(3):299-304. PubMed ID: 21272268
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival.
Cook JR; Hsi ED; Worley S; Tubbs RR; Hussein M
Am J Clin Pathol; 2006 Apr; 125(4):615-24. PubMed ID: 16627271
[TBL] [Abstract][Full Text] [Related]
16. [Transition to aggressive phase in a multiple myeloma patient with IgH/CCND1 translocation and diffuse osteosclerotic lesions].
Hatsuse M; Fuchida S; Okano A; Murakami S; Shimazaki C
Rinsho Ketsueki; 2016 Apr; 57(4):483-8. PubMed ID: 27169455
[TBL] [Abstract][Full Text] [Related]
17. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
18. JAK2V617F-positive essential thrombocythemia and multiple myeloma with IGH/CCND1 gene translocation coexist, but originate from separate clones.
Kuroda J; Matsumoto Y; Tanaka R; Kurita K; Kobayashi T; Shimizu D; Kimura S; Ashihara E; Horiike S; Shimazaki C; Taniwaki M
Acta Haematol; 2008; 120(3):177-81. PubMed ID: 19129688
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
